Adhesions: An update

Modern Management of Endometriosis

Volumn , Issue , 2005, Pages 93-104

  Sachar, Vikas ^a   Diamond, Michael P ^a   Sutton, Christopher ^b,c  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750625739     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (81)

1. Diamond M, Daniel JF, Feste J, et al. Adhesion reformation and de novo adhesion formation prevention after reproductive pelvic surgery. Fertil Steril 1987; 47: 864-866.
2. Ellis H, Moran BJ, Thompson JN, et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet 1999; 353: 1476-1480.
3. Lower AM, Hawthorn RJS, Ellis H. The impact of adhesions on hospital readmissions over ten years after 8849 open gynecologic operations: an assessment from the Surgical and Clinical Adhesions Research Study. Br J Obstet Gynaecol 2000; 107: 855-862.
4. Ray NF, Denton WG, Thamer M, et al. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. Am Coll Surg 1998; 186: 1-9.
5. Thompson JN, Paterson-Brown S, Harbourne T, et al. Reduced human peritoneal plasminogen activating activity: possible mechanism of adhesion formation. Br J Surg 1989; 76: 382-384.
6. Doody KJ, Dunn RC, Buttram VC Jr. Recombinant tissue plasminogen activator reduces adhesion formation in a rabbit uterine horn model. Fertil Steril 1989; 51: 509-512.
7. Menzies, D, Ellis H. Intra-abdominal adhesions and their prevention by topical tissue plasminogen activator. J R Soc Med 1989; 82: 534-535.
8. Dijkstra FR, Nieuwenhuijzen M, Reijnen MM. Recent clinical developments in pathophysiology, epidemiology, diagnosis and treatment of intra-abdominal adhesions. Scand J Gastroenterol Suppl 2000; 35(Suppl 232): 52-59.
9. Farquhar C, Vanderkerckhove P, Watson A, et al. Barrier agents for preventing adhesions after surgery for subfertility. Cochrane Database Syst Rev 2003; 3: 1-49.
10. Duffy DM, diZerega GS. Is peritoneal closure necessary? Obstet Gynecol Surv 1994; 49: 817-822.
11. Menzies D, Ellis H. Intestinal obstruction from adhesions - how big is the problem? Ann R Coll Surg Engl 1990; 72: 60-63.
12. DeCherney A, Hurd W, Pagidas K, et al. Techniques and tools to prevent pelvic adhesions. An Expert Panel. OBG Manage 2003; 15: 20-40.
13. Wiseman D. Polymers for the prevention of surgical adhesions. In: Domb AJ, ed. Polymeric site-specific pharmacotherapy. New York: John Wiley and Sons; 1994: 370-421.
14. Krinsky A, Haseltine F, DeCherney A. Peritonal fluid accumulation with dextran 70 instilled at time of laparoscopy. Fertil Steril 1984; 41: 647-649.
15. Pfeffer W. Adjuvants in tubal surgery. Fertil Steril 1980; 33: 245-256.
16. Watson A, Vanderkerckhove P, Lilford R. Liquid and fluid agents for preventing adhesions after surgery for subfertility. Cochrane Database Syst Rev 2003; 3: 1-49.
17. Adhesion Study Group. Reduction of postoperative pelvic adhesions with intraperitoneal 32% dextran 70: a prospective, randomized clinical trial. Fertil Steril 1983; 40: 612-619.
18. Adoni A, Addatto-Levy R, Mogle P, et al. Postoperative pleural effusion caused by dextran. Int J Gynecol Obstet 1980; 18: 243-247.
19. Magyar D, Hayes M, Spiritos N, et al. Is intraperitoneal dextran 70 safe for routine gynecologic use? Am J Obstet Gynecol 1985; 152: 198-201.
20. Borten M, Seibert C, Taymor M. Recurrent anaphylactic reaction to intraperitoneal dextran 70 used for prevention of postsurgical adhesions. Obstet Gynecol 1983; 61: 755-757.
21. Duffy DM, diZerega GS. Adhesion controversies: pelvic pain as a cause of adhesions, crystalloids in preventing them. J Reprod Med 1996; 5: 19-26.
22. Shear L, Swartz C, Shinaberger JA, et al. Kinetics of peritoneal fluid absorption in adult man. N Engl J Med 1965; 272: 123-127.
23. Wiseman D, Trout JR, Diamond M. The rates of adhesion development and the effects of crystalloid solutions on adhesion development in pelvic surgery. Fertil Steril 1998; 70: 702-711.
24. diZerega GS, Campeau JD. Use of instillates to prevent intraperitoneal adhesions. Infertil Reprod Med Clin N Am 1994; 5: 463-478.
25. Naether OGL. Significant reduction of adnexal adhesions following laparoscopic electrocautery of the ovarian surface (LEOS) by lavage and artificial ascites. Gynaecol Endosc 1995: 4; 17-19.
26. Lundorff P, Hahlin M, Kallfelt B, et al. Adhesion formation after laparoscopic surgery in tubal pregnancy: a randomized trial versus laparotomy. Fertil Steril 1991; 55: 911-915.
27. Operative Laparoscopy Study Group. Postoperative adhesion development after operative laparoscopy: evaluation at early second-look procedures. Fertil Steril 1991; 55: 700-704.
28. Luciano AA, Maier DB, Kock EI, et al. A comparative study of postoperative adhesions following laser surgery by laparoscopy versus laparotomy in the rabbit model. Obstet Gynecol 1989; 74: 220-224.
29. Hidlebaugh DA, Vulgaropulos S, Orr RK. Treating adnexal masses. Operative laparoscopy versus laparotomy. J Reprod Med 1997; 47: 551-558.
30. Baptista ML, Bonsack MW, Felemoviscius I, et al. Abdominal adhesions to prosthetic mesh evaluated by laparoscopy and electron microscopy. J Am Coll Surg 2000; 190: 271-280.
31. Liakakos T, Thomakos N, Fine PM, et al. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg 2001; 18: 260-273.
32. Wiseman DM, Gottlick LE, Diamond MP. Effect of thrombin-induced hemostasis on the efficacy of an absorbable adhesion barrier. J Reprod Med 1992; 37: 766-770.
33. De Cherney AH, di Zerega GS. Clinical problem of intraperitoneal postsurgical adhesion formation following general surgery and the use of adhesion prevention barriers. Surg Clin North Am 1997; 77: 671-688.
34. Wiseman D. Polymers for the prevention of surgical adhesions. In: Domb AJ, ed: Polymeric site-specific pharmacotherapy. New York: John Wiley and Sons; 1994: 370-421.
35. Prevention of postsurgical adhesions by INTERCEED(TC7), an absorbable adhesion barrier: a prospective randomized multicenter clinical study. INTERCEED(TC7) Adhesion Barrier Study Group. Fertil Steril 1989; 51: 933-938.
36. Diamond MP, Linsky CB, Cunningham T, et al. Synergistic effects of Interceed (TC7) and heparin in reducing adhesion formation in the rabbit uterine horn model. Fertil Steril 1991; 55: 389-394.
37. Diamond MP, Linsky CB, Cunningham T, et al. Adhesion reformation: reduction by the use of Interceed (TC7) plus heparin. J Gynecol Surg 1991; 7: 1-6.
38. Sahin Y, Saglam A. Synergistic effects of carboxymethylcellulose and low molecular weight heparin in reducing adhesion formation in the rat uterine horn model. Acta Obstet Gynecol Scand 1994; 73: 70-73.
39. Reid RL, Lie K, Spence JE, et al. Clinical evaluation of the efficacy of heparin-saturated Interceed for prevention of adhesion reformation in the pelvic sidewall of the human. In: Diamond MP, diZerega GS, Linsky CB, et al, eds. Gynecologic surgery and adhesion prevention. New York: Wiley-Liss; 1993: 261-264.
40. Reid RL, Hahn PM, Spence JE, et al. A randomized clinical trial of oxidized regenerated cellulose adhesion barrier (Interceed, TC7) alone or in combination with heparin. Fertil Steril 1997; 67: 23-29.
41. Andrade-Gordon P, Strickland S. Interaction of heparin with plasminogen activators and plasminogen. Biochemistry 1986; 25: 4033-4040.
42. Orita H, Campeau JD, Gale J, et al. Differential secretion of plasminogen activator activity by postsurgical activated macrophages. J Surg Res 1986; 41: 569-573.
43. Markwardt F, Klocking HP. Heparin-induced release of plasminogen activator. Haemostasis 1977; 6: 370-374.
44. Wiseman DM, Trout JR, Franklin R, et al. Metaanalysis of the safety and efficacy of an adhesion barrier (Interceed TC7) in laparotomy. J Reprod Med 1999; 44: 325-331.
45. 2 laser vaporization laparoscopy. In Proceedings of the Eighth Annual Meeting of the European Society of Human Reproduction and Embryology, 1992: 61. [Abstract]
46. diZerega GS. Use of adhesion prevention barriers in ovarian surgery, tubalplasty, ectopic pregnancy, endometriosis, adhesiolysis, and myomectomy. Curr Opin Obstet Gynecol 1996; 8(3): 230-237.
47. Sawada T, Nishizawa H, Nishio E, et al. Postoperative adhesion prevention with an oxidized regenerated cellulose adhesion barrier in infertile women. J Reprod Med 2000; 45: 387-389.
48. Haney AF, Doty ED. Murine peritoneal injury and de novo adhesion formation caused by oxidized-regenerated cellulose (Interceed TC7) but not expanded polytetrafluoroethylene (Gore-Tex surgical membrane). Fertil Steril 1992; 57: 202-208.
49. Boyers SP, Diamond MP, DeCherney AH. Reduction of postoperative adhesions in the rabbit with Gore-Tex surgical membrane. Fertil Steril 1988; 49: 1066-1070.
50. Prophylaxis of pelvic sidewall adhesions with Gore-Tex surgical membrane: a multicenter clinical investigation. The Surgical Membrane Study Group. Fertil Steril 1992; 57: 921-923.
51. Haney AF, Hesla J, Hurst BS, et al. Expanded polytetrafluoroethylene (Gore-Tex) Surgical Membrane is superior to oxidized regenerated cellulose (Interceed TC7) in preventing adhesions. Fertil Steril 1995; 63: 1021-1026.
52. An expanded polytetrafluoroethylene barrier (Gore-Tex Surgical Membrane) reduced post-myomectomy adhesion formation. Myomectomy Adhesion Multicenter Study Group. Fertil Steril 1995; 63: 491-493.
53. Haney AF. Removal of surgical barriers of expanded polytetrafluoroethylene at second-look laparoscopy was not associated with adhesion formation. Fertil Steril 1997; 68: 721-723.
54. Grow DR, Seltman HJ, Coddington CC, et al. The reduction of postoperative adhesions by two different barrier methods versus control in cynomolgus monkeys: a prospective randomized, crossover study. Fertil Steril 1994; 61: 1141-1146.
55. Diamond MP. Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized multicenter clinical study. Fertil Steril 1996; 66: 904-910.
56. Becker JM, Dayton MT, Fazio VW, et al. Prevention of postoperative abdominal adhesions by a sodium hyaluronate based bioresorbable membrane: a prospective, randomized, double-blind multicenter trial. J Am Coll Surg 1996; 183: 297-306.
57. Kelly KA, Pemberton JH, Wolff BG, et al. Ileal pouch-anal anastomosis. Curr Probl Surg 1992; 64: 64-131.
58. Wietske WV, Tseng LNL, Eijkman HJM, et al. Fewer intraperitoneal adhesions with use of hyaluronic acidcarboxymethylcellulose membrane; a randomized clinical trial. Ann Surg 2002; 235: 193-199.
59. Khaitan L, Scholz S, Houston H, et al. Results after laparoscopic lysis of adhesions and placement of Seprafilm for intractable abdominal pain. Surg Endosc 2003; 17: 247-253.
60. Bowers D, Raybon RB, Wheeless CR Jr. Hyaluronic acidcarboxymethylcellulose film and perianastomotic adhesions in previously irradiated rats. Am J Obstet Gynecol 1999; 181: 1335-1338.
61. Moreira H Jr, Wexner SD, Yamaguchi T, et al. Use of bioresorbable membrane (sodium hyaluronate _ carboxymethylcellulose) after controlled bowel injuries in a rabbit model. Dis Colon Rectum 2000; 43: 182-187.
62. Beck DE, Cohen Z, Fleshman JW, et al for the Adhesion Study Group Steering Committee. A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine. Dis Colon Rectum 2003; 46: 1310-1319.
63. Burns JW, Skinner K, Colt MJ, et al. A hyaluronate based gel for the prevention of postsurgical adhesions: evaluation in two animal species. Fertil Steril 1996; 66: 814-821.
64. Ferland R, Mulani D, Campbell PK. Evaluation of a sprayable polyethylene glycol adhesion barrier in a porcine efficacy model. Hum Reprod 2001; 16(12): 2718-2723.
65. Mettler L, Audebert A, Lehmann-Willenbrock E, et al. A prospective clinical trial of SprayGel as a barrier to adhesion formation: interim analysis. Poster and presentation at the 10th Congress of the European Society for Gynecologic Endoscopy, Lisbon, Portugal. Bologna: Monduzzi Editore; 2001.
66. Pellicano M, Bramante S, Cirillo D, et al. Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomised, controlled study. Fertil Steril 2003; 80(2): 441-444.
67. Acunzo G, Guida M, Pellicano M, et al. Effectiveness of auto-cross-linked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic adhesiolysis: a prospective randomised study. Hum Reprod 2003; 18(9): 1918-1921.
68. Reich H. New techniques in advanced operative laparoscopy. In: Sutton CJG, ed. Baillière’s Clin Obstet Gynaecol 1989; 3: 655-681.
69. Davies DS. Kinetics of icodextrins. Perit Dial Int 1994; 14: S45-S50.
70. Rosen DMB, Sutton CJG. Outcome measures and adhesion formation: pain and postsurgical adhesion. In: diZerega GS, ed. Peritoneal surgery. New York: Springer-Verlag; 1999: 321-327.
71. deZerega GS. Biochemical events in peritoneal tissue repair. Eur J Surg 1997; S577: 10-16.
72. Harris ES, Morgan RF, Rodeheaver GT. Analysis of the kinetics of peritoneal adhesion formation in the rat and evaluation of potential antiadhesive agents. Surgery 1995; 117: 663-669.
73. Gilbert JA, Peers EM, Brown CB, et al. Intraperitoneal fluid dynamics of 4% icodextrin in non-ESRC patients. Perit Dial Int 1999; 19: S79.
74. Verco SJS, Peers EM, Brown CB, et al. Development of a novel glucose polymer solution (icodextrin) for adhesion prevention: pre-clinical studies. Hum Reprod 2000; 15(8): 1764-1772.
75. diZerega G, Verco SJS, Young P, et al. A randomized controlled pilot study of the safety and efficacy of 4% icodextrin solution (Adept) in the reduction of adhesions following laparoscopic gynecologic surgery. Hum Reprod 2002; 17: 1031-1038.
76. Peers E, Brown CB. Adept Adhesion Study Group. Adept (4% icodextrin): change in American Fertility Society score in a large, multicentre, randomised, double-blind clinical trial. Abstract F11.02 presented at the 14th Annual Congress of the International Society for Gynecologic Endoscopy; 3-6 April 2005, London.
77. Peers E, Brown CB. Adept Adhesion Study Group. Adept (4% icodextrin): significantly reduces post-surgical adhesion incidence in a large randomized, double-blind clinical trial. Abstract F13.05 presented at the 14th Annual Congress of the International Society for Gynecologic Endoscopy; 3-6 April 2005, London.
78. Wilson MS, Menzies D, Knight AD, et al. Demonstrating the clinical use and cost effectiveness of adhesion reduction strategies. Colorectal Dis 2002; 4: 355-360.
79. Tulandi T, Collins J, Burrows E, et al. Treatmentdependent and treatment-independent pregnancy among women with periadnexal adhesions. Am J Obstet Gynecol 1990; 162: 354-357.
80. Pados G, Camus M, De Munck L, et al. Laparscopic application of Interceed (TC7). Hum Reprod 1992; 7: 1141-1143.
81. Ethicon Communication. Urgent voluntary market withdrawal of Gynecare Intergel Adhesion Prevention Solution. March 28, 2003.